Health Canada says it is working with manufacturers to make diabetes drugs, including Ozempic, more available during a worldwide shortage fuelled by high demand that’s expected to last into the new year.
It says Novo Nordisk, which markets Ozempic, is expecting a shortage in Canada of the 0.25 mg, 0.5 mg and 1 mg injection pens until early 2024.

Posted in


Leave a Comment

You must be logged in to post a comment.